Human Genome Epidemiology Literature Finder
|
Records 1 - 8 (of 8 Records) |
| Query Trace: Pancreatic Neoplasms and CDKN2B[original query] |
|---|
| Copy number variation at 6q13 functions as a long-range regulator and is associated with pancreatic cancer risk. Carcinogenesis 2012 Jan 33 (1): 94-100. Huang Liming, Yu Dianke, Wu Chen, Zhai Kan, Jiang Guoliang, Cao Guangwen, Wang Chunyou, Liu Yu, Sun Menghong, Li Zhaoshen, Tan Wen, Lin Dongx |
| Genetic polymorphisms in the 9p21 region associated with risk of multiple cancers. Carcinogenesis 2014 Dec 35 (12): 2698-705. Li Wen-Qing, Pfeiffer Ruth M, Hyland Paula L, Shi Jianxin, Gu Fangyi, Wang Zhaoming, Bhattacharjee Samsiddhi, Luo Jun, Xiong Xiaoqin, Yeager Meredith, Deng Xiang, Hu Nan, Taylor Philip R, Albanes Demetrius, Caporaso Neil E, Gapstur Susan M, Amundadottir Laufey, Chanock Stephen J, Chatterjee Nilanjan, Landi Maria Teresa, Tucker Margaret A, Goldstein Alisa M, Yang Xiaohong |
| A functional variant rs1537373 in 9p21.3 region is associated with pancreatic cancer risk. Molecular carcinogenesis 2019 1 58 (5): 760-766. Zhu Beibei, Zhu Ying, Tian Jianbo, Shen Na, Li Jiaoyuan, Lou Jiao, Ke Juntao, Yang Yang, Gong Yajie, Gong Jing, Chang Jiang, Miao Xiaoping, Zhong Ro |
| Clinical histopathological features and CDKN2A/CDK4/MITF mutational status of patients with multiple primary melanomas from Bologna: Italy is a fascinating but complex mosaic. Italian journal of dermatology and venereology 2020 Mar . Dika Emi, Patrizi Annalisa, Rossi Cesare, Turchetti Daniela, Miccoli Sara, Ferracin Manuela, Veronesi Giulia, Scarfì Federica, Lambertini Marti |
| Molecular Landscape and Prognostic Biomarker Analysis of Advanced Pancreatic Cancer and Predictors of Treatment Efficacy of AG Chemotherapy. Frontiers in oncology 2022 12 844527. Du Juan, Qiu Xin, Lu Changchang, Zhu Yahui, Kong Weiwei, Xu Mian, Zhang Xin, Tang Min, Chen Jun, Li Qi, Li Aimei, He Jian, Gu Qing, Wang Lei, Qiu Yudong, Liu Baor |
| Characterization of the genomic landscape in large-scale Chinese patients with pancreatic cancer. EBioMedicine 2022 3 77 103897. Zhang Xiaofei, Mao Tiebo, Zhang Bei, Xu Haiyan, Cui Jiujie, Jiao Feng, Chen Dongqin, Wang Yu, Hu Jiong, Xia Qing, Ge Weiyu, Li Shumin, Yue Ming, Ma Jingyu, Yao Jiayu, Wang Yongchao, Wang Yanling, Shentu Daiyuan, Zhang Xiao, Chen Shiqing, Bai Yuezong, Wang Yuexiang, Zhang Xuebin, Liu Qiang, Sun Yongwei, Fu Deliang, Liu Yingbin, Xiong Lei, Wang Liw |
| Association between a polymorphic variant in the CDKN2B-AS1/ANRIL gene and pancreatic cancer risk. International journal of cancer 2022 12 . Giaccherini Matteo, Farinella Riccardo, Gentiluomo Manuel, Mohelnikova-Duchonova Beatrice, Kauffmann Emanuele Federico, Palmeri Matteo, Uzunoglu Faik, Soucek Pavel, Petrauskas Dalius, Cavestro Giulia Martina, Zykus Romanas, Carrara Silvia, Pezzilli Raffaele, Puzzono Marta, Szentesi Andrea, Neoptolemos John, Archibugi Livia, Palmieri Orazio, Milanetto Anna Caterina, Capurso Gabriele, van Eijck Casper H J, Stocker Hannah, Lawlor Rita T, Vodicka Pavel, Lovecek Martin, Izbicki Jakob R, Perri Francesco, Kupcinskaite-Noreikiene Rita, Götz Mara, Kupcinskas Juozas, Hussein Tamás, Hegyi Péter, Busch Olivier R, Hackert Thilo, Mambrini Andrea, Brenner Hermann, Lucchesi Maurizio, Basso Daniela, Tavano Francesca, Schöttker Ben, Vanella Giuseppe, Bunduc Stefania, Petrányi Ágota, Landi Stefano, Morelli Luca, Canzian Federico, Campa Danie |
| [A real-world study of first-line albumin-bound paclitaxel in the treatment of advanced pancreatic cancer in China]. Zhonghua zhong liu za zhi [Chinese journal of oncology] 2024 12 46 (11): 1038-1048. J Du, X Qiu, J Y Ni, Q L Wang, F Tong, H Z Sha, Y H Zhu, L Qi, W Cai, C Gao, X W Wei, M B Chen, Z Y Qian, M H Cai, M Tao, C L Wang, G C Zheng, H Jiang, A W Dai, J Wu, M H Zhao, X Q Li, B Lu, C B Wang, B R L |
- Page last reviewed:Feb 1, 2024
- Content source: